Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

EP-CAM Polyclonal Antibody, 50ul[BT-AP02986] Culture Plate Inserts Members of the glypican-related integral

SKU: 89406122481

4.6
USD162.00 USD192.00

Pay in 4 interest-free payments of $40.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Live Spec

EP-CAM Polyclonal Antibody, 50ul[BT-AP02986] Culture Plate Inserts Members of the glypican-related integralEPCAM encodes a carcinoma associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in EPCAM result in congenital tufting enteropathy.

Store: clickpoint.com.au · Domain: clickpoint.com.au

Description

Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage

nucleolus site being often related to storage

Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density

platelet dense granules

Translocations between this gene on chromosome 9 and the T-cell receptor beta-chain locus on chromosome 7 have been associated with activation of the T-cell acute lymphocytic leukemia 2 gene and T-cell acute lymphoblastic leukemia

EP-CAM Polyclonal Antibody, 50ul[BT-AP02986] Culture Plate Inserts Members of the glypican-related integralEPCAM encodes a carcinoma associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in EPCAM result in congenital tufting enteropathy.

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products